StonvexLoading…
StonvexStonvexStonvexCore line items from FRPH's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $42.85M | $41.77M | $41.51M | $37.48M |
Operating Income | $7.03M | $11.70M | $11.70M | $8.00M |
Net Income | $3.33M | $6.38M | $5.30M | $4.57M |
EPS (Diluted) | $0.18 | $0.34 | $0.28 | $0.24 |
Total Assets | $735.14M | $728.49M | $709.17M | $701.08M |
Total Liabilities | $279.49M | $259.37M | $261.19M | $256.87M |
Cash & Equivalents | $105.36M | $148.62M | $157.56M | $177.50M |
Free Cash Flow OCF − CapEx | $-21.46M | $-22.21M | $21.75M | $-5.28M |
Shares Outstanding | 19.11M | 19.05M | 18.97M | 9.46M |